Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of SIM0718 in Adult and Adolescent Patients With Moderate to Severe Atopic Dermatitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating SIM0718 for efficacy and safety in adults and adolescents with moderate to severe atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• SIM0718

Snippet

Sponsor: Simcere Pharmaceutical Co., Ltd | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED